← Browse by Condition
Medical Condition
erectile dysfunction
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for erectile dysfunction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — erectile dysfunction Clinical Trials
How many clinical trials are currently recruiting for erectile dysfunction?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for erectile dysfunction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for erectile dysfunction?
erectile dysfunction research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a erectile dysfunction clinical trial?
Eligibility criteria for erectile dysfunction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05574868
Recruiting
Enrollment
182 pts
Location
Australia
Sponsor
Rigicon, Inc.
NCT06273592
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
Montefiore Medical Center
NCT06147791
Recruiting
Enrollment
50 pts
Location
Italy
Sponsor
A.O.U. Città della Salute e de...
NCT06945315 Phase 3
Recruiting
Enrollment
196 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
NCT06639763
Recruiting
Enrollment
1,000 pts
Location
Belgium
Sponsor
University Hospital, Ghent
NCT05868668
Recruiting
Enrollment
186 pts
Location
United States
Sponsor
The Cleveland Clinic
NCT07366970
Recruiting
Enrollment
40 pts
Location
Egypt
Sponsor
Cairo University
NCT03466619
Recruiting
Enrollment
100 pts
Location
Egypt
Sponsor
Tanta University
Related Conditions
prostate cancer (1) transgenderism (1) gender dysphoria (1) sexual dysfunction (1) erectile dysfunction due to arterial insufficiency (1) erectile dysfunction due to arterial disease (1) chronic pelvic pain syndrome (1) chronic prostatitis (1) erectile dysfunction following radical prostatectomy (1) erectile dysfunction following radiation therapy (1) diabetes mellitus (1) vitamin d deficiency (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology